Rethinking Behavioral Health and Care Continuity with AI

Behavioral health has long lagged behind the rest of the healthcare industry. While hospitals and specialty care practices have evolved their recordkeeping, imaging, and data analysis from manually-ridden paperwork formats to automated and digitized tools over the past two decades, much of behavioral care still operates on episodic visits separated by weeks of silence, and less precision medicine.

Patients often struggle most in the gaps between appointments. This is precisely when clinicians have the least visibility into patient experiences and mental health state. That structural gap, combined with increasing clinician burnout rates, high staff turnover, and rising demand, drives the need for a different model of care. Several healthcare leaders and providers are now recognizing an opportunity where clinical practice must appropriately intersect with applied technology to make care feel more connected, personalized, and responsive to patient needs for outcomes and quality of care and reality of their experiences.

Jimini Health: Leading the Shift Toward Continuous Care

The prevailing viewpoint among behavioral health executives is that the next three to five years will bring a move away from purely episodic treatment toward something more continuous.

Technology must help clinicians and care-providing teams understand what is happening in a patient’s life between visits, way earlier in the care value-chain to create opportunities to intervene before a situation escalates. This distinction matters in today’s time where AI tools and adoption have proliferated across healthcare use cases and settings, but continuity remains a blind spot. Continuity is not only a convenience feature in behavioral health; it is a clinical variable to drive adherence to treatment plans and sustained patient engagement. In fact, these two are the strongest predictors of long-term outcomes. When patients disengage early, both their health and the organizations treating them pay the price.

The idea became the foundation of Jimini Health, founded by Chief Executive Officer and Co-founder Luis Voloch and his founding team. Voloch spent much of his career building analytical systems for high-stakes environments. He previously co-founded an AI-driven cancer immunotherapy company that reached a valuation exceeding $1 billion, and he has taught data science at the graduate level. Before that, he was at Palantir’s ML team, and also won MIT’s Best MSc Thesis Award in Computer Science (among all Phd track students).

After reviewing the behavioral health landscape, Voloch rightly concluded that the field was decades behind others in adopting modern tools. The need of the hour was not just to embed AI and generic chatbots that could automate patient queries and replace clinicians, but to leverage the technology’s capabilities to extend the reach of care to patients. This way, it would help keep providers in the loop with the patients during the moments that matter most, without adding to clinician and administrative workload.

“We believe that AI-powered care technologies will be the critical and missing third component in a trifecta, alongside human clinicians and drugs,” Voloch said.

The platform helps patients stay engaged with their treatment plans, reinforces evidence-based therapeutic approaches, supports medication adherence, and provides structured support between appointments.

Sage: Not a Point-Based Tool, but A Member of the Care Team

Jimini’s central argument is that behavioral health cannot be served by the tools that have flooded the consumer market. General-purpose automation, generic chatbots and direct-to-consumer therapy apps are not built around an individual patient’s clinical context, and they operate outside clinical supervision. The company’s flagship platform, Sage, functions as a supervised member of the care team rather than a standalone application. The platform helps patients stay engaged with their treatment plans, reinforces evidence-based therapeutic approaches, supports medication adherence, and provides structured support between appointments. Every interaction is grounded in the patient’s care plan and remains visible to the supervising clinician.

In a field where continuity and adherence directly affect outcomes, Sage is built with rigorous attention to safety, privacy, governance, performance oversight, and regulatory compliance. For providers and clinical staff, Sage is designed to operate within existing clinical workflows without disrupting routine and critical operations, keeping all the concerned team informed and in control of patient contacts between appointments.

Built for Compliance and Oversight

Jimini has structured Sage to support HIPAA-compliant deployments and to operate within federal and state healthcare requirements, with licensed clinicians maintaining oversight of patient interactions. The company has also invested significantly in clinical governance, safety frameworks, and operational processes that prioritize accountability and responsible deployment.

Additionally, the platform’s safety frameworks were developed with input from clinical advisors affiliated with institutions including Harvard Medical School, Stanford, Yale and Dartmouth, as well as researchers with experience at Google DeepMind. For behavioral health executives weighing adoption, that level of clinical rigor from the team is important.

No More Administrative Burden

Beyond patient engagement, Sage eases the administrative load on clinical teams. Providers routinely spend significant time reconstructing and interpreting what happened between appointments, reviewing patient updates, treatment and patient history notes, and check-ins to understand a patient’s status. Sage organizes that information into an easy-to-review and clinically relevant format. This helps reduce administrative overhead on the clinicians and providers of care without needing to be available 24/7, making time for more value-added work that requires professional judgment: clinical decision-making and direct patient care.

Early Results and Evidence of Sage

Jimini reports that across its early deployments, both patients and clinicians have been willing to engage with the platform. The company says Sage has been used to support patients and reduce early churn in care. This problem carried both clinical and commercial consequences for behavioral health organizations.

One metric Jimini tracks closely is patient adherence, given its strong correlation with long-term outcomes. According to the company, several early deployments have shown meaningful improvement in adherence alongside strong patient acceptance and clinician engagement. Jimini says it intends to publish whitepapers and peer-reviewed studies over the coming year to substantiate those observations.

Success Indicators that Matter to The Executives

As technology tools and their adoption proliferate across healthcare, executive leaders and IT decision-makers are asking harder questions, demanding tangible evidence of safety and compliance. Lately, they have also been evaluating AI tools and platforms based on their deployment paths and feasibility without disrupting existing operations, as well as assurance that the platforms’ capabilities can readily be embedded into an accountable clinical environment.

Jimini has been tracking measurable outcomes, recognizing improved adherence as a consistent result across use cases. Adherence translates into better patient outcomes and a direct effect on an organization’s bottom line, which behavioral health leaders need to justify their investment.

The Road Ahead

In the near term, Jimini plans to expand partnerships with behavioral health organizations and broaden Sage’s capabilities across additional care settings, clinical support configurations, patient populations, and diagnoses. A recent $17 million seed round, which brings the company’s total funding to more than $25 million, is intended to support that growth.

Looking further out, Voloch pointed to the policy environment as a key lever. Beyond working with behavioral health organizations directly, he said he would like to see more programs modeled on federal reimbursement initiatives that reward technology for driving clinical outcomes, particularly AI deployed alongside, not in place of, human clinicians.

For an industry that has long treated care as a series of disconnected appointments, the new imperative is straightforward: close the gaps between visits, keep clinicians at the center, and let the results speak for themselves.

If you are experiencing a mental health crisis please reach out to 988 for free and confidential support 24/7. If you are experiencing a life threatening emergency, please call 911 or go to your nearest emergency room.